| Govindbhai Parshottambhai Kachhadiya, MD | |
|
169 Martin Ave, Ephrata, PA 17522-1724 | |
| (717) 721-8195 | |
| (717) 733-6010 |
| Full Name | Govindbhai Parshottambhai Kachhadiya |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 29 Years |
| Location | 169 Martin Ave, Ephrata, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093980518 | NPI | - | NPPES |
| 1013977730026 | Medicaid | PA | |
| 190001VOU | Other | PA | MEDICARE |
| Facility Name | Location | Facility Type |
|---|---|---|
| Wellspan Ephrata Community Hospital | Ephrata, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wellspan Medical Group | 1951213115 | 1946 |
News Archive
As the midterm election rhetoric intensifies, so does the voter confusion about the landmark federal health law passed last March, according to the tracking poll by the Kaiser Family Foundation.
When older adults lose control as they move into residential care, they adapt and accept what cannot be changed in order to stay happy. According to a new study, by Jaclyn Broadbent, Shikkiah de Quadros-Wander and Jane McGillivray from Deakin University in Australia, when it comes to satisfaction in later life the ability to accept what cannot be changed is as important as the feeling of being able to exert control.
Salix Pharmaceuticals, Ltd. today announced that the Company has acquired rights to Lumacan™ from Photocure, a Norwegian specialty pharmaceutical company. Lumacan is a novel agent designed to assist in the detection of precancerous and cancerous lesions in the colon.
Achaogen, a clinical stage biopharmaceutical company addressing the issue of multi-drug resistant bacterial infections through the discovery and development of innovative, broad-spectrum antibiotics, today announced the results of a Phase 1 trial and preclinical data on its lead drug candidate ACHN-490 at the 49th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) Annual Meeting in San Francisco, CA.
› Verified 1 days ago
| Entity Name | Wellspan Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750480299 PECOS PAC ID: 1951213115 Enrollment ID: O20040220000815 |
News Archive
As the midterm election rhetoric intensifies, so does the voter confusion about the landmark federal health law passed last March, according to the tracking poll by the Kaiser Family Foundation.
When older adults lose control as they move into residential care, they adapt and accept what cannot be changed in order to stay happy. According to a new study, by Jaclyn Broadbent, Shikkiah de Quadros-Wander and Jane McGillivray from Deakin University in Australia, when it comes to satisfaction in later life the ability to accept what cannot be changed is as important as the feeling of being able to exert control.
Salix Pharmaceuticals, Ltd. today announced that the Company has acquired rights to Lumacan™ from Photocure, a Norwegian specialty pharmaceutical company. Lumacan is a novel agent designed to assist in the detection of precancerous and cancerous lesions in the colon.
Achaogen, a clinical stage biopharmaceutical company addressing the issue of multi-drug resistant bacterial infections through the discovery and development of innovative, broad-spectrum antibiotics, today announced the results of a Phase 1 trial and preclinical data on its lead drug candidate ACHN-490 at the 49th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) Annual Meeting in San Francisco, CA.
› Verified 1 days ago
| Entity Name | Ephrata Community Hospital |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1083615587 PECOS PAC ID: 4981514445 Enrollment ID: O20040419000567 |
News Archive
As the midterm election rhetoric intensifies, so does the voter confusion about the landmark federal health law passed last March, according to the tracking poll by the Kaiser Family Foundation.
When older adults lose control as they move into residential care, they adapt and accept what cannot be changed in order to stay happy. According to a new study, by Jaclyn Broadbent, Shikkiah de Quadros-Wander and Jane McGillivray from Deakin University in Australia, when it comes to satisfaction in later life the ability to accept what cannot be changed is as important as the feeling of being able to exert control.
Salix Pharmaceuticals, Ltd. today announced that the Company has acquired rights to Lumacan™ from Photocure, a Norwegian specialty pharmaceutical company. Lumacan is a novel agent designed to assist in the detection of precancerous and cancerous lesions in the colon.
Achaogen, a clinical stage biopharmaceutical company addressing the issue of multi-drug resistant bacterial infections through the discovery and development of innovative, broad-spectrum antibiotics, today announced the results of a Phase 1 trial and preclinical data on its lead drug candidate ACHN-490 at the 49th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) Annual Meeting in San Francisco, CA.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Govindbhai Parshottambhai Kachhadiya, MD 3421 Concord Rd, York, PA 17402-9001 Ph: (717) 851-4740 | Govindbhai Parshottambhai Kachhadiya, MD 169 Martin Ave, Ephrata, PA 17522-1724 Ph: (717) 721-8195 |
News Archive
As the midterm election rhetoric intensifies, so does the voter confusion about the landmark federal health law passed last March, according to the tracking poll by the Kaiser Family Foundation.
When older adults lose control as they move into residential care, they adapt and accept what cannot be changed in order to stay happy. According to a new study, by Jaclyn Broadbent, Shikkiah de Quadros-Wander and Jane McGillivray from Deakin University in Australia, when it comes to satisfaction in later life the ability to accept what cannot be changed is as important as the feeling of being able to exert control.
Salix Pharmaceuticals, Ltd. today announced that the Company has acquired rights to Lumacan™ from Photocure, a Norwegian specialty pharmaceutical company. Lumacan is a novel agent designed to assist in the detection of precancerous and cancerous lesions in the colon.
Achaogen, a clinical stage biopharmaceutical company addressing the issue of multi-drug resistant bacterial infections through the discovery and development of innovative, broad-spectrum antibiotics, today announced the results of a Phase 1 trial and preclinical data on its lead drug candidate ACHN-490 at the 49th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) Annual Meeting in San Francisco, CA.
› Verified 1 days ago
Dr. Michael Xuan Le, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 169 Martin Ave, Ephrata, PA 17522 Phone: 717-721-4740 Fax: 717-738-6872 | |
William D Loretan, DO Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 446 N Reading Rd, Suite 301, Ephrata, PA 17522 Phone: 717-733-6546 Fax: 717-733-6011 | |
Heather D Mccord, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 169 Martin Ave, Ephrata, PA 17522 Phone: 717-721-4740 Fax: 717-738-6872 | |
Dr. Il Jun Chon, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 446 N Reading Rd, Suite 301, Ephrata, PA 17522 Phone: 717-733-6546 Fax: 717-733-6010 | |
Marino D Mallozzi, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 446 N Reading Rd, Suite 301, Ephrata, PA 17522 Phone: 717-733-6546 Fax: 717-733-6010 | |
Abdul Majeed, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 169 Martin Ave, Ephrata, PA 17522 Phone: 717-721-4740 Fax: 717-738-6872 | |
Kunal N Patel, DO Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 169 Martin Ave, Ephrata, PA 17522 Phone: 717-721-4740 Fax: 717-738-6872 |